D68.31Header code — not billable

Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

Short description: Hemorrhagic disorder due to intrns circ anticoag,antib,inhib

Chapter
3. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Category
D68
Effective date
October 1, 2026

Related codes in category D68

D68Other coagulation defectsD68.0Von Willebrand diseaseD68.00Von Willebrand disease, unspecifiedYesD68.01Von Willebrand disease, type 1YesD68.02Von Willebrand disease, type 2D68.020Von Willebrand disease, type 2AYesD68.021Von Willebrand disease, type 2BYesD68.022Von Willebrand disease, type 2MYesD68.023Von Willebrand disease, type 2NYesD68.029Von Willebrand disease, type 2, unspecifiedYesD68.03Von Willebrand disease, type 3YesD68.04Acquired von Willebrand diseaseYes

Frequently asked questions

What is ICD-10 code D68.31?

D68.31 is an ICD-10-CM diagnosis code for Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors.

Is D68.31 a billable code?

No. D68.31 is a category/header code, not billable on its own — use one of its more specific child codes instead.

What ICD-10-CM chapter is D68.31 in?

D68.31 falls under Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.

When did D68.31 become effective?

D68.31 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.

What other codes are related to D68.31?

D68.31 belongs to category D68, which includes 12 other codes — see the related codes list on this page.

ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.